Skip to main content
NRIX
NASDAQ Life Sciences

Nurix Posts $443.5M Cash, Roche Deal Closing Nears with $700M Upfront

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$24.82
Mkt Cap
$2.553B
52W Low
$8.195
52W High
$25.085
52W Position info
203% above low
Off High info
1.1% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

NRIX has more than doubled off its 52-week low of $8.195.

Summary

Nurix reported Q2 2026 financials with $9.0M revenue, $89.5M net loss, and $443.5M cash as of May 31, with pro-forma cash of ~$1.14B including the expected $700M Roche upfront. The Roche collaboration, announced in June, is advancing toward close—subject to HSR clearance—with the upfront payment expected within 30 days of effectiveness, as part of a deal valued at up to $2.3 billion. Updated Phase 1b data showed strong ORR of 92.9% in BTKi-experienced, BCL2i-naïve patients and 84.2% in BTKi-naïve patients, reinforcing bexobrutideg's profile. Enrollment continues in the pivotal Phase 2 DAYBreak CLL-201 trial, with preparations underway for the Phase 3 DAYBreak CLL-306 study. The cash position and upcoming Roche payment significantly extend the runway as the pipeline advances.

At the time of this announcement, NRIX was trading at $24.82 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $8.20 to $25.09. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

NRIX - Latest Insights

NRIX
Nov 03, 2026, 4:02 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.03
Real-time Price: $13.87 info
Change: -$8.16 (-37%) info
Market Cap: $1.512B info
NRIX
Nov 03, 2026, 4:01 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $17.88
Real-time Price: $13.87 info
Change: -$4.01 (-22%) info
Market Cap: $1.512B info
NRIX
Oct 13, 2026, 6:21 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $22.50
Real-time Price: $13.87 info
Change: -$8.63 (-38%) info
Market Cap: $1.512B info
NRIX
Oct 13, 2026, 6:19 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $22.50
Real-time Price: $13.87 info
Change: -$8.63 (-38%) info
Market Cap: $1.512B info
NRIX
Oct 12, 2026, 4:05 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $23.06
Real-time Price: $13.87 info
Change: -$9.19 (-40%) info
Market Cap: $1.512B info